Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.80 USD
+0.02 (0.05%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $41.84 +0.04 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
Income Statements
Fiscal Year end for Surmodics, Inc falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 133 | 100 | 105 | 95 | 100 |
Cost Of Goods | 25 | 20 | 17 | 15 | 14 |
Gross Profit | 108 | 80 | 88 | 80 | 86 |
Selling & Adminstrative & Depr. & Amort Expenses | 102 | 102 | 81 | 81 | 80 |
Income After Depreciation & Amortization | 5 | -22 | 7 | -1 | 6 |
Non-Operating Income | 1 | 0 | 0 | 0 | 1 |
Interest Expense | 3 | 1 | 0 | 0 | 0 |
Pretax Income | 2 | -22 | 6 | -1 | 8 |
Income Taxes | 4 | 5 | 2 | -3 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | -27 | 4 | 1 | 8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -2 | -27 | 4 | 1 | 8 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 14 | -13 | 15 | 6 | 14 |
Depreciation & Amortization (Cash Flow) | 9 | 9 | 8 | 7 | 8 |
Income After Depreciation & Amortization | 5 | -22 | 7 | -1 | 6 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 14.03 | 13.92 | 13.99 | 13.81 | 13.78 |
Diluted EPS Before Non-Recurring Items | 0.16 | -0.95 | 0.37 | 0.13 | 0.72 |
Diluted Net EPS (GAAP) | -0.11 | -1.96 | 0.30 | 0.08 | 0.55 |
Fiscal Year end for Surmodics, Inc falls in the month of September.
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 31.96 | 30.55 | 27.97 | 52.48 |
Cost Of Goods | NA | 7.10 | 8.80 | 7.04 | 6.92 |
Gross Profit | NA | 24.86 | 21.75 | 20.93 | 45.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 24.20 | 22.07 | 23.39 | 24.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.66 | -0.32 | -2.46 | 21.41 |
Non-Operating Income | NA | 0.39 | 0.49 | 0.56 | 0.12 |
Interest Expense | NA | 0.88 | 0.90 | 0.90 | 0.88 |
Pretax Income | NA | 0.17 | -0.72 | -2.79 | 20.65 |
Income Taxes | NA | -0.08 | 0.06 | -9.48 | 13.30 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 0.25 | -0.79 | 6.69 | 7.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.25 | -0.79 | 6.69 | 7.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 14.18 | 14.10 | 14.15 | 14.07 |
Diluted EPS Before Non-Recurring Items | NA | 0.07 | 0.00 | 0.53 | 0.52 |
Diluted Net EPS (GAAP) | NA | 0.02 | -0.06 | 0.48 | 0.52 |